Vision health perspectives on Breaking Bad: Ophthalmic sequelae of methamphetamine use disorder

被引:1
|
作者
Huang, Ye [1 ]
Nguyen, Nam V. V. [1 ]
Mammo, Danny A. A. [2 ]
Albini, Thomas A. [3 ]
Hayek, Brent R. R. [4 ]
Timperley, Brent D. D. [1 ]
Krueger, Ronald R. R. [1 ]
Yeh, Steven [1 ]
机构
[1] Univ Nebraska Med Ctr, Stanley M Truhlsen Eye Inst, Dept Ophthalmol & Visual Sci, Omaha, NE 68198 USA
[2] Cleveland Clin, Cole Eye Inst, Cleveland, OH USA
[3] Univ Miami, Bascom Palmer Eye Inst, Miller Sch Med, Miami, FL USA
[4] North Georgia Eye Clin, Gainesville, GA USA
来源
FRONTIERS IN TOXICOLOGY | 2023年 / 5卷
基金
美国国家卫生研究院;
关键词
methamphetamine; vision loss; ocular injury; keratitis; neurotoxicity; retinopathy; OCULAR MANIFESTATIONS; ABUSE; HIV; INJECTION; KERATITIS; BLINDNESS; HAZARDS; SEX; MEN;
D O I
10.3389/ftox.2023.1135792
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Methamphetamine use has become a rampant public health issue that not only causes devastating consequences to the user but also poses a burden to surrounding communities. A spectrum of ophthalmic sequelae is associated with methamphetamine use and includes episcleritis, scleritis, corneal ulceration, panophthalmitis, endophthalmitis, retinal vasculitis, and retinopathy. In many instances, prompt recognition of the condition and associated infectious process and early initiation of antimicrobial therapy are crucial steps to preventing vision loss. In this review, we summarize the reported ocular complications that may result from methamphetamine use in addition to several postulated mechanisms regarding the ocular toxicity of methamphetamine. The increasing prevalence of methamphetamine use as a public health threat highlights the need for continued investigation of this ophthalmologic issue.
引用
收藏
页数:8
相关论文
共 23 条
  • [1] Addressing methamphetamine use in opioid use disorder treatment: Clinical perspectives
    Danisman, Mustafa
    Ispir, Gamze Zengin
    Katar, Kuebra Sezer
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2024, 26 (01)
  • [2] Pharmacists' perspectives on methamphetamine use disorder in the Australian community setting
    Makki, Ali
    Day, Carolyn
    Chaar, Betty B.
    PHARMACY EDUCATION, 2024, 24 (01): : 772 - 781
  • [3] World Health Organization High Priority Pathogens: Ophthalmic Disease Findings and Vision Health Perspectives
    Kuthyar, Sanjana
    Anthony, Casey L.
    Fashina, Tolulope
    Yeh, Steven
    Shantha, Jessica G.
    PATHOGENS, 2021, 10 (04):
  • [4] Characterizing trends in methamphetamine-related health care use when there is no ICD code for "methamphetamine use disorder"
    Shearer, Riley D.
    Shippee, Nathan D.
    Winkelman, Tyler N. A.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 127
  • [5] Smartphone-based contingency management for methamphetamine use disorder: A qualitative analysis of clinician perspectives
    Chang, Yanni
    Ketron, Adam
    Cohn, Eliza
    Saxon, Andrew
    Iles-Shih, Matt
    Duncan, Mark
    Hallgren, Kevin
    AMERICAN JOURNAL ON ADDICTIONS, 2024, 33 (02): : 174 - 174
  • [6] The reflections of health service providers on implementing contingency management for methamphetamine use disorder in Australia
    Clay, Simon
    Wilkinson, Zachary
    Ginley, Meredith
    Arunogiri, Shalini
    Christmass, Michael
    Membrey, Dean
    Maccartney, Paul
    Sutherland, Rachel
    Colledge-Frisby, Samantha
    Marshall, Alison D.
    Nagle, Jack
    Degenhardt, Louisa
    Farrell, Michael
    Mcketin, Rebecca
    DRUG AND ALCOHOL REVIEW, 2024, 43 (05) : 1313 - 1322
  • [7] The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder
    Aryan, Nazanin
    Banafshe, Hamid Reza
    Farnia, Vahid
    Shakeri, Jalal
    Alikhani, Mostafa
    Rahimi, Habibollah
    Sehat, Mojtaba
    Mamsharifi, Peyman
    Ghaderi, Amir
    Omidi, Abdollah
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2020, 15 (01)
  • [8] Mental Health and Substance Use Disorder Comorbidity among Methamphetamine-Using Men Who have Sex with Men
    Fletcher, Jesse B.
    Swendeman, Dallas
    Reback, Cathy J.
    JOURNAL OF PSYCHOACTIVE DRUGS, 2018, 50 (03) : 206 - 213
  • [9] The therapeutic effects of methylphenidate and matrix-methylphenidate on addiction severity, craving, relapse and mental health in the methamphetamine use disorder
    Nazanin Aryan
    Hamid Reza Banafshe
    Vahid Farnia
    Jalal Shakeri
    Mostafa Alikhani
    Habibollah Rahimi
    Mojtaba Sehat
    Peyman Mamsharifi
    Amir Ghaderi
    Abdollah Omidi
    Substance Abuse Treatment, Prevention, and Policy, 15
  • [10] Accessibility Barriers to Medications for Opioid Use Disorder Treatment: A Qualitative Study of Perspectives From Women With Opioid Use Disorder and Health and Criminal Justice Professionals
    Skogseth, Emma
    Brant, Kristina
    Latkin, Carl
    Jones, Abenaa
    DRUG AND ALCOHOL DEPENDENCE, 2025, 267